Histotripsy, a non-invasive therapy using ultrasound to treat various ailments, has seen significant success in clinical trials. Many countries have embraced this innovative medical procedure, resulting in improved patient outcomes. Yet, it remains largely inaccessible in Australia.

The United States-based company HistoSonics has reported successful clinical trials on their website, with histotripsy showing high efficiency in treating conditions such as liver cancer and benign prostatic hyperplasia non-invasively. This therapy presents a low-complication treatment option that could help many Australians who are suffering.

According to the Cancer Council, over 50,000 people succumbed to cancer in Australia in 2021. With histotripsy, we could potentially reduce these numbers and provide our citizens with more treatment options. It is crucial for our government to investigate and consider introducing histotripsy therapy in Australia.

We encourage the Australian Department of Health to further investigate the clinical evidence supporting histotripsy therapy. Moreover, we urge them to explore partnerships with companies like HistoSonics and make histotripsy a viable treatment option in Australia. Join us in fostering a healthier Australia with more treatment options. Please sign the petition.